Contact us
Request a Quote

Toda Fluronadiag

Infectious Diseases

Test de diagnostic rapide des virus de la grippe de type A&B et de la COVID-19

Toda Fluronadiag est un test de diagnostic rapide pour la détection qualitative des antigènes de la COVID-19 et des virus de la grippe de type A&B dans des échantillons d’écouvillons nasopharyngés.

  • SARS-CoV-2 (COVID-19)
  • Influenza A&B
  • Interpretation time
    15 minutes
  • Sampling
    Nasopharyngeal swab

A rapid, accurate, and convenient test

Les avantages du Toda Fluronadiag.

MULTI-DETECTION

Simultaneous analysis of COVID-19 and influenza A & B viruses in a single test, enabling differential diagnosis.

CONVENIENT

Individual, ready-to-use buffer vials and a single-use diluent included for each test, limiting contamination risks.

EFFICIENT

Contributes to appropriate interventions and optimized care.

ACCURATE, SENSITIVE, AND SPECIFIC

See performance table below. 

Performance

PERFORMANCE COVID-19 INFLUENZA A INFLUENZA B
Sensitivity 96.08% >99.9% >96.0%
Specificity 99.5% >99.9% >99.9%
Accuracy 98.9% >99.9% >99.0%

An accurate test starts with proper technique

Découvrez en 5 étapes simples comment utiliser le Toda Fluronadiag. 

This test is intended for use by healthcare professionals only.

Practical information

Tous les coffrets Toda Fluronadiag contiennent :

  • 10 ou 20 tests au format cassette
  • 10 ou 20 écouvillons
  • 10 ou 20 flacons de diluant
  • 1 detailed package insert

References

  • Box of 10 tests: 24CO2-10
  • Box of 20 tests: 24CO2-20
  • Single test: 24CO2-1

The test should be stored at room temperature (between +2 and +30 °C).

Helpful documents

Catalog & product sheet

Infectious Diseases Catalogue

Fiche produit Toda Fluronadiag

Download

For any additional information requests

"*" indicates required fields

Last Name*
Email*
Do you have a question or a specific need? Our team is here to help.
GDPR

Learn more

1. Why is it important to differentiate between COVID-19 and influenza A & B?

COVID-19 and influenza A and B viruses exhibit very similar symptoms: fever, cough, fatigue, respiratory discomfort, etc. However, they are caused by different viruses and require distinct management approaches.

Differentiating between these infections allows for:

  • Prescribing appropriate treatment: the antivirals used differ depending on the causative virus.
  • Avoiding unnecessary prescriptions: particularly antibiotics, which are ineffective against viruses.
  • Implementing appropriate isolation measures: to limit transmission, especially in high-risk environments (hospital, nursing home, daycare, etc.).
  • Ensuring improved epidemiological surveillance: to adapt public health responses.
  • Adapt patient communication: to reassure them or, conversely, to expedite their care.

This distinction is particularly crucial during winter periods, when these viruses co-circulate and co-infections are possible.

The COVID-19 and influenza (Influenza A & B) viruses cause very similar symptoms: cough, fever, fatigue, nasal congestion, respiratory discomfort... It is therefore virtually impossible to determine visually which virus is responsible, especially during winter when these viruses co-circulate.

Instead of performing two separate tests, the Fluronadiag test allows for:

  • Saving time (results for all 3 viruses in 15 minutes)
  • Reducing patient discomfort (only one nasal swab is required)
  • Limiting costs and consumable usage
  • Improving immediate patient management (guidance, isolation, treatment)

Furthermore, the test detects co-infections, meaning the simultaneous presence of multiple viruses, which can occur in children or elderly individuals and may exacerbate the illness.

Thus, it is a rapid, efficient, and comprehensive triage tool, particularly valuable in emergency departments, pediatrics, community medicine, or communal settings (nursing homes, nurseries, hospitals).

Yes, it is entirely possible to be simultaneously infected by multiple respiratory viruses, such as COVID-19 and influenza. This phenomenon is referred to as a co-infection.

Co-infections are particularly common among:

  • Young children, whose immune systems are still immature
  • Elderly or immunocompromised individuals
  • Hospitalized or institutionalized patients, who are exposed to multiple viruses simultaneously

Having multiple viruses simultaneously can make symptoms more severe, complicate diagnosis, and increase the risk of respiratory complications, especially in vulnerable individuals.

Complementary diagnostics in this range

Discover the full range

Need information, training, or a quote?

Tell us what you are looking for, and we will promptly provide a tailored solution.

Contact us
Back to Top